Concepedia

Yulius Y. Setiady

YY

Statistics

Publications

22

Citations

1.5K

H-Index

19

Active since

1995

Affiliations

ImmunoGen (United States)(Current)

University of Virginia

Nara Institute of Science and Technology

The University of Texas MD Anderson Cancer Center

Sidney Kimmel Cancer Center

Yulius Y. Setiady is an author at ImmunoGen (United States) specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

1995–2020

22

Publications

22

Effects of Drug–Antibody Ratio on Pharmacokinetics, Biodistribution, Efficacy, and Tolerability of Antibody–Maytansinoid Conjugates

Xiuxia Sun, Jose F. Ponte, Nicholas C. Yoder et al. · Bioconjugate Chemistry · 2017 · 242 citations

, , +23

<i>In vivo</i> depletion of CD4<sup>+</sup>FOXP3<sup>+</sup> Treg cells by the PC61 anti‐CD25 monoclonal antibody is mediated by FcγRIII<sup>+</sup> phagocytes

Yulius Y. Setiady, Jennifer A. Coccia, Peter U. Park · European Journal of Immunology · 2009 · 213 citations

, , +19

Sphingosine Kinase 2 Is Required for Modulation of Lymphocyte Traffic by FTY720

Yugesh Kharel, Sangderk Lee, Ashley H. Snyder et al. · Journal of Biological Chemistry · 2005 · 209 citations · Full text

, , +19

A CD123-targeting antibody-drug conjugate, IMGN632, designed to eradicate AML while sparing normal bone marrow cells

Yelena Kovtun, Gregory E. Jones, Sharlene Adams et al. · Blood Advances · 2018 · 174 citations · Full text

Tobacco mitotic cyclins: cloning, characterization, gene expression and functional assay

Yulius Y. Setiady, Masami Sekine, Norimitsu Hariguchi et al. · The Plant Journal · 1995 · 83 citations · Full text

, , +14

1–5 of 22